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The oxytocin/oxytocin receptor (OT/OTR) system has been reported to influence a variety of physiological, behavioural, 
and emotional processes in humans. There are a wide range of studies focusing on their role in parturition, lactation and 
behaviour. More recent studies have investigated the novel effects of OT/OTR system including inflammation and 
miRNAs, as well as the effect of their genetic polymorphisms on the onset of labour and parturition. OT also appears to 
have a great influence in cardiomyocyte differentiation and heart homeostasis, and an age-specific regulation of muscle 
maintenance and regeneration. This review will summarize the previously established role of OT/OTR system as well as 
the studies on their novel roles, and highlight the potential therapeutic approaches. 
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Oxytocin 
Oxytocin (OT) is classically considered to have a 
fundamental role in the mechanism of human labour. In  
1906, it was first noted that the posterior pituitary extract had 
the ability to drive uterine contractions [1]. Subsequently, the 
active factor was identified to be oxytocin, a potent activator 
of contractions in the pregnant uterus (from the Greek oxus, 
meaning sharp and tokos, referring to childbirth). OT was 
first introduced into clinical practice as a uterotonin to 
stimulate labour within 1940s [2]. By 1953, the biochemical 
structure of OT was determined [3], and the gene was cloned 
30 years later [4].  
OT is a nonapeptide hormone (Cys-Tyr-Ile-Gln-Asn-Cys- 
Pro-Leu-Gly-NH2) with a disulfide bridge between the two 
cysteines. The presence of a disulfide bridge results in a 
six-amino acid cyclic part and a COOH-terminal α-amidated 
three-residue tail. This structure of OT is very similar to 
other nonapeptide neurohypophysial hormones. These can be 
classified into two families; vasopressin and OT families, 
depending on their amino acid at position 8, where 
vasopressin family contains a basic amino acid (Lys, Arg) 
and OT family contains a neutral amino acid. It has been 
reported that OT and vasopressin genes are on the same 
chromosome locus in opposite directions and therefore arose 
as a result of common ancestral gene duplication. However, 
the variance in these key amino acids can promote 
differences in the polarity of the peptides, enabling them to 
bind to their respective receptors [5].  
It has been established that OT is synthesized principally 
in the magnocellular neurons of the hypothalamic 
paraventricular (PVN) and supraoptic (SON) nuclei [6]. The 
produced peptide is then transported down the neuronal 
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projections (axons) of the posterior pituitary gland where it is 
released to modulate its function. Rossoni et al. have 
demonstrated that some of the OT from the hypothalamus is 
transported to the dendrites in order to regulate the firing 
patterns of the OT neuronal network [7]. Moreover, OT has 
been found to be synthesized locally in humans to contribute 
to the processes of labour [8]. Apart from mediating 
parturition, OT is also important for milk ejection during 
lactation [9], maternal behaviour, sexual receptivity and 
partnership bonding [10], thereby facilitating species 
propagation. 
Oxytocin and Parturition 
Oxytocin drives uterine contractions 
In general, the OT/OTR system within the pregnant uterus 
plays a significant role in two distinct physiological functions; 
stimulation of uterine contractions and production of 
prostaglandins (PG). The effect of oxytocin on human 
uterine smooth muscle can be distinguished into at least three 
components including the increase in frequency of 
contractions, transient increase in the base tone, and 
long-lasting increase in the amplitude and duration of phasic 
contractions.  
Stimulation of contractions by OT/OTR system in smooth 
muscle cells, such as uterine myometrial cells or mammary 
gland myoepithelial cells, is driven by an increase in 
intracellular Ca2+ that leads to a calmodulin-mediated 
activation of myosin light chain kinase (MLCK) [11]. Binding 
of OT to the OTR activates the heterotrimeric protein 
complex of a G-protein consisting of an α, β and γ subunits 
[12]. In the myometrium, binding of OT to its receptor leads to 
release of the Gαq/11 and Gβγ (from Gαi) subunits, leading to 
activation of phospholipase C (PLC) isoforms β1, β3 and β2, 
β3, respectively [13]. This enzyme catalyzes hydrolysis of 
phosphatidylinositol-4, 5-bisphosphate (PIP2) to inositol-1, 4, 
5-trisphosphate (IP3) and diacylglycerol (DAG). The increase 
in intracytoplasmic Ca2+ is further amplified by IP3 which 
promotes release of Ca2+ from the sarcoplasmic reticulum, 
and a Ca2+ influx from the extracellular space through 
membrane Ca2+ channels [14]. Concurrently, the DAG 
generated by the actions of PPLCβ on PIP2 stimulates protein 
kinase C (PKC), maximising the force generation during the 
phasic contraction (Figure 1). Further Ca2+-promoted 
processes include gene transcription and protein synthesis. 
In addition to regulating smooth muscle contractility by 
electromechanical coupling, pharmacomechanical coupling 
can also be accounted for the physiological mechanisms that 
regulate OT-induced contractions [15]. Activation of OTR in 
human myometrium can convert inactive RhoA-GDP to its 
active form, RhoA-GTP through guanine nucleotide 
exchange factors (GEFs). RhoA-GTP acts via Rho kinase 
(ROK) to phosphorylate the regulatory subunit of MLC, 
leading to contractions [16]. There has been records of RhoA 
and ROK upregulation in human myometrium during 
pregnancy [17] and ROK has been shown to mediate 
OT-induced myometrial contractions.  
Oxytocin as an inflammatory mediator 
Although labor onset is defined clinically by myometrial 
contractions, these are preceded by fetal membrane 
remodeling. The fetal membranes (composed of amnion and 
chorion) undergo carefully regulated biochemical changes 
that modulate functional pathways precipitating labor and 
birth. Labor is antedated by NF-κB activation and 
inflammatory stimulation in both the myometrium and the 
Figure 1. OT/OTR signaling pathways involved in myometrial 
contraction. OT binds to OTR and OTR coupled with Gα/β/γ leads 
to activation of PLC, which hydrolyses PIP2 to IP3 and DAG. 
Activated PLC and IP3 cause release of Ca2+ from the sarcoplasmic 
reticulum. Both OTR and DAG activate PKC to initiate MAPK 
cascade which in turn causes increased cPLA2 activity and PG 
synthesis. OTR also triggers RhoA/ROK cascade and results in 
increase in MLC kinase activation. Intra-cytoplasmic Ca2+ increases 
further via membrane Ca2+ channels and these combined with 
calmodulin activates MLC kinase. The increase in PG synthesis and 
MLC activation induce myometrial contractions. OT: oxytocin, OTR: 
oxytocin receptor, PLC: phospholipase, PIP2: phosphatidylinositol 
4,5-bisphosphate, DAG: diacylglycerol, PKC: protein kinases type C, 
MLC: myosin light-chain, MAPK: mitogen-activated protein kinase, 
cPLA2: cytosolic phospholipase A2, ROK: RhoA associated protein 
kinase. 
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amnion [18, 19], which triggers an inflammatory cascade 
involving elevation of inflammatory cytokines as well as PG, 
particularly PGE2 [20]. It has been noted that OT stimulates an 
increase in cytoplasmic phospholipase A2 activity and 
induce COX-2 expression in Chinese hamster ovary (CHO) 
cells [21] as well as in cultured human myometrial cells and 
amnion cells [22]. These are two major enzymes required for 
PG synthesis. PG synthesis is one of the key steps involved 
in the onset of human labour [23]. There are various 
mechanisms of action PGs utilise to trigger labour. PGs can 
lead to cervical ripening and dilation, placental separation [24] 
and fetal membrane rupture by inducing metrix 
metalloproteinase (MMP) activity [25]. Another well 
described action of PGs is their role in promoting myometrial 
contractility. PGF2α induced contractions are partly mediated 
by electromechanical coupling as well as 
pharmacomechanical coupling, resembling that of oxytocin 
induced contractions [26]. Release of PGF2α by decidual 
OT/OTR system have been shown to enhance uterine 
contractions as well as promoting cervical ripening and  
Figure 2. Models for OT/OTR signaling in the inflammatory activation in myometrium 
and amnion. In myometrium, OT binding to OTR drives the activation of MAPKs; ERK1/2 
and p38 kinase, and canonical NF-κB signaling cascade involving p65/p50 heterodimers. 
MAPKs and the NF-κB dimers induce expression of pro-labour genes such as COX-2, 
prostaglandins, and proinflammatory cytokines and chemokines independently. In amnion, 
OT binding to OTR drives the sequential activation of MAPKs; ERK1/2 and p38 kinase, and 
the canonical NF-κB signaling cascade involving p65 homodimers. The NF-κB dimers 
translocate to the nucleus and binds to κB sites to induce expression of pro-labour genes. 
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Table 1. Validated gene targets of oxytocin-regulated miRNAs. 
miRNA Change in expression with 
oxytocin 
Validated gene targets References 
hsa-miR-146a-5p Decrease NF-κB activity 
IL-8, IL-6, MMP9 
α-smooth muscle actin 
[36-38] 
hsa-miR-146b-3p Increase NF-κB regulation 
platelet-derived growth factor beta polypeptide 
(PDGFB) 
[39] 
hsa-miR-196a-3p Decrease No matches  
hsa-miR-876-5p Decrease No validated targets  
Gene targets of oxytocin-regulated miRNAs were identified using the miRTarBase platform. 
lueolysis. Inhibition of PG synthesis decreases the 
upregulation of OT binding sites as well as the effect of OT 
on promoting myometrial contractions [27].  
Collectively the increases in inflammatory stimulation 
play a role in driving myometrium to switch from a quiescent 
state to contractile state [19, 20]. However, the stimuli 
triggering inflammatory activation in normal human 
parturition are not fully understood. Recent study has shown 
that the role for OT in the onset of human labor exceeds 
stimulation of myometrial contractions and involves 
concurrent activation of inflammatory pathways. OT 
modulates key inflammatory pathways that promote the 
laboring phenotype revealing a novel role for OT in the onset 
of labor [28]. OT acts as an inflammatory mediator in human 
gestational tissues by inducing PGE2 and inflammatory 
cytokine/chemokine release through a novel mechanism. In 
myometrium, OT activates the established canonical pathway 
involving p65/p50 heterodimers with no crosstalk between 
NF-κB and MAPKs (Figure 2). In amnion however, OT 
signalling is markedly different. NF-κB activation involves 
only p65 nuclear translocation and this is dependent on 
crosstalk with MAPKs. The subsequent translocation of 
activated NF-κB into the nucleus drives the expression of 
numerous pro-labor genes including COX-2, inflammatory 
cytokines and chemokines (Figure 2). Therefore, it is 
important to consider the dual role of OT in both stimulation 
of inflammation and onset of uterine contractions in the 
management of preterm and term labor.  
Modulation of miRNAs and oxytocin 
Since the discovery of their existence almost two decades 
ago, miRNAs (non-coding, single-stranded 19-25 nucleotide 
molecules) have been identified as a powerful 
post-transcriptional regulator of about a third of the human 
genome [29, 30]. Typically, these small RNA regulate gene 
expression by degradation of mRNA transcript or 
translational repression through binding to the 3` 
untranslated region (UTR) of the target gene. There has been 
increasing evidence highlighting the role for miRNAs in 
vascular smooth muscle as well as in female reproductive 
tissues, where they have been shown to be associated with 
differentiation, proliferation and embryo implantation [31-33]. 
More recently, miRNAs have been implicated in hormone 
responsiveness and the regulation of key gene expression 
pathways involved in parturition [34].  
A recent study in human myometrium have described a 
novel pathway in which OT contributes to the onset of labour 
by regulating the expression of miRNAs, hsa-miR-146a-5p, 
hsa-miR-196a-3p, hsa-miR-876-5p, and hsa-miR-146b-3p 
(Table 1) [35]. Notably, hsa-miR-146a-5p was shown to be 
significantly reduced in myometrial samples of 
oxytocin-treated women and cultured myocytes. In numerous 
cancer cell studies, hsa-miR-146a-5p has been shown to be a 
suppressor of NF-κB activity ultimately reducing the 
expression of NF-κB-regulated genes including the key 
labor-associated genes IL-8, IL-6 and MMP9 [36, 37]. In 
addition, hsa-miR-146a-5p was found to down-regulate the 
expression of α-smooth muscle actin in human dermal 
fibroblasts [38], which is an essential component for the 
contractile machinery of uterine smooth muscle. The miRNA 
hsa-miR-146b-3p was increased in myometrial samples of 
OT-induced labors and is thought to be involved in the 
regulation of NF-κB activation [39]. It has also been 
implicated in the regulation of inflammatory cytokine, 
platelet-derived growth factor beta polypeptide (PDGFB), 
which was shown to be released by uterine myocytes in 
response to stretch [40]. OT-induced labor led to a significant 
decrease in hsa-miR-876-5p; however further research is 
required to understand the role of this miRNA in myometrial 
function as there is a lack of validated gene targets.  
MiRNAs have not only been reported to be regulated by 
OT signaling to promote laboring phenotype, but also to 
increase the myometrial sensitivity to OT. Another study by 
Renthal et al. reported an increase in miR-200 family of 
Inflammation & Cell Signaling 2015; 2: e739. doi: 10.14800/ics.739; ©  2015 by Sung Hye Kim, et al. 
http://www.smartscitech.com/index.php/ics 
 
Page 5 of 9 
 
miRNAs in laboring murine and human myometrium at term. 
The family of miR-200 was found to be associated with 
labour by modulating the expression of the two critical 
contraction-associated proteins including connexin-43 
(CX-43) and OTR [41], thus preparing the myometrium for 
contractions and enhancing the myometrial sensitivity to OT.  
SNPs in oxytocin pathway and the risk for PTB 
Predicting preterm birth (PTB) takes various factors into 
consideration including risk factors, fetal fibronectin, 
cervical length, bacterial vaginosis, and presence of other 
biomarkers such as cytokines, chemokines, albumin and 
vitamin D-binding protein (VDBP) [42, 43]. The women’s 
history of previous PTB is one of the major risk factors and 
predictors for PTB [44]. It has been reported that 20% of 
women with previous PTB have successive PTB with the 
same partner, although changing paternity appears to reduce 
the risk by a third [45, 46]. Recent genome-wise linkage 
analyses in recurrent PTB and association studies have 
identified a cassette of candidate genes associated with PTB, 
and also provided evidence for maternal and fetal genetic 
variations predisposing to PTB [47-49].  
To date, OTR gene polymorphisms have been investigated 
mainly in relation to psychiatric disorders and diseases [50]. 
There are dozens of single nucleotide polymorphisms (SNPs) 
identified within the OTR gene however, the association 
between these SNPs and the risk of PTB remains largely 
unknown. Kim et al. have identified three rare variants of 
OTR (rs202138705, rs200498154 and rs201783860) by 
resequencing and have reported that these coding variants 
appear to contribute to the increased risk of prematurity [51]. 
Characterization of the effects of these genetic variants in 
vitro showed a significant decrease in OT-specific binding 
compared to control cells, which highlights the importance of 
these residues in the function of the receptor. Previous study 
have confirmed that these variants are located in the second 
extracellular loops of OTR that determines agonist binding 
and selectivity [52]. Despite the potential for diagnostic or 
therapeutic relevance of OTR mutations in the risk of PTB, 
larger studies have not been carried out to confirm these 
findings.  
Currently, there has not been a report linking any 
individual OTR polymorphism to PTB, which led to the 
investigation of their combined effects. A haplotype analysis 
in Caucasian women by Kuessel et al. revealed a 
combination of OTR gene polymorphisms (rs2254298 A 
allele, rs2228485 C allele and rs237911 G allele) that is 
significantly associated with increased risk of PTB [53]. 
However, further studies investigating the role of OTR gene 
polymorphism and PTB and examination of the impact of the 
mutations on other downstream biological pathways are 
required to fully understand their significance as diagnostic 
or therapeutic targets. 
Oxytocin and Lactation 
Oxytocin plays a key role in mammals as a mediator of 
milk-ejecting activity of the lactating mammary gland. A 
complementary role in regulating milk production through 
control of prolactin secretion has long been considered. 
Previous gene ablation studies in mice with inactivated OT 
gene demonstrated that OT is required for milk ejection from 
the glands but not the production of milk [9, 54]. Treatment 
with OT antagonist, atosiban, inhibited milk ejection and this 
inhibition was reversed with the administration of OT [55, 56]. 
OT leads to milk ejection by stimulating contraction of 
myoepithelial cells that form a basket-like network around 
the alveoli and milk ducts in the mammary gland [57]. This is 
often in concert with suckling. The suckling of the infant 
promotes the release of OT from the posterior pituitary and it 
interacts with OTR of the myoepithelial cells to induce 
intracellular calcium release, leading to contraction .  The 
myoepithelial contracion reduces the alveolar lumen 
resulting in the expulsion of milk from alveoli into the 
lactiferous ducts, and smooth muscle alpha-actin (ACTA2) 
have been shown to be involved in enhancing contractile 
force required [58]. The contrations occur 4-10 times per 10 
minutes with each contraction lasting approximately 1 
minute [59], which coincides with the pulses of OT in the 
blood stream [60]. 
High-affinity binding sites for OT were demonstrated in 
particulate fractions from mammary glands and confirmed 
that similar to myometrial cells, alveolar myoepithelial cells 
contain OTR. Studies in rodents suggest that there is a 
gradual gestational-dependent increase in the mammary 
gland OTR expression that reaches a maximum in the first 
week postpartum [61, 62] whilst uterine OTR undergo a rapid 
decrease [63, 64]. It is possible that circulating OT is able to 
switch its target organs during parturition and lactation via a 
tissue-specific regulation of OTR expression. 
Oxytocin and Maternal Behavior 
The first potential effect of OT on maternal behaviour was 
demonstrated in 1979, where it was shown to induce 
maternal behaviour in non-pregnant rats [65]. Unlike human 
and non-human primates, majority of mammalian species 
rarely exhibit spontaneous maternal behaviour. In sheep, 
ewes are only maternally responsive towards a lamb after the 
onset of parturition [66], and OT plays a significant role in 
inducing maternal responses post-partum. The brain OT 
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levels in sheep were elevated with vagino-cervical 
stimulation occurring at the time of birth, which can have 
immediate effect on inducing full maternal responses in 
non-pregnant, estrogen-primed animals [67]. Similar increase 
in OT was observed in human cerebrospinal fluid at the time 
of birth [68]. However, there is lack of evidence linking OT to 
mouse, rat or human maternal behaviour. The OT gene 
knockout mouse strain, C57BI6, is spontaneously maternal 
when presented with pups [69], and mere presence of pups 
evokes maternal responses in rats. The role of brain OT 
release in the control of maternal behaviour may be 
facilitatory.  
There have been reports on the effects of OT on social and 
bonding behaviours. In sheep, OT has been shown to 
facilitate the formation of olfactory recognition associated 
with the maternal bond as OTR expression and OT 
immunoreactivity increases significantly in the olfactory bulb, 
which is a key site of formation of olfactory memory [70]. 
This was further confirmed as OT infusions given to 
hormone-primed animals led to selective bonding with their 
lambs in 2 to 4 hours [71]. OT infusions also facilitate social 
recognition in rats [72], and OT knockout male mice showed 
impaired social recognition skills [73]. A study in OTR 
knockout mice demonstrated displays of several aberrations 
in their social behaviours, including mother-offspring 
interaction [74]. It has been suggested that the diversity in the 
genetic regulation of OTR rather than the peptide itself may 
bring about natural variation in social behaviour [75]. Similar 
to bonding behaviours of sheep, human mothers also have 
the ability to selectively recognise the smell of their own 
infants within 30 minutes of birth, and in a recent study, OT 
has been reported to be associated with human parent-infant 
bonding [76]. Moreover, mothers with low plasma 
concentration of OT during pregnancy has been shown to 
have increased risk for postpartum depression [77]. 
OT affects behaviour of both sexes especially in early life. 
Various studies on the effect of OT on social cognition and 
behaviour have been conducted with men, and these studies 
have shown that OT helps to promote trusting and protective 
social behaviour [76, 78], enhance facial emotion recognition 
[79], and memory for positive social information [80]. 
Moreover, disturbed OT signlaing due to functional 
polymorphism and epigenetic silencing causes increase in 
impulsive, aggressive temperament as well as violent, 
unemotional traits in males [81, 82]. 
Diminished OT is related to multiple pathlogical states 
including autism, osteoporosis and depression. Therefore, 
administration of OT improves social cognition in socially 
impaired individuals with autism and depression, alter 
dysfunctional cognitions in social phobia [75], and improve 
psychological well-being in the elderly. This introduces the 
therapeutic potential of manipulating OT/OTR system to 
enhance stress-alleviation and social support, however, this 
should be approached cauciously as there is increasing 
evidence that OT treatments can have asocial or negative 
conseuqneces such as increase in perception of threat [83] and 
enhancement of fear conditioning [84]. 
Oxytocin and Muscle Regeneration 
In the 1980’s, a novel function of the neurophyseal 
hormone, OT, has emerged. It was found to have a great 
influence on cardiomyocyte differentiation, cardiac healing 
and heart homeostasis [85, 86]. OT appears to play an extensive 
role in the cardiovascular system as there is an abundant 
functional OT system present in the early developing heart, 
and OT drives differentiation of embryonic stem cells into 
cardiomyocytes that respond to cardioactive drugs [87]. Plante 
et al. have reported that OT treatment can protect obese 
diabetic mice from cardiomyopathy via normalization of 
cardioprotective genes such as Gata4, Anp and Bnp, 
maintenance of cardiac structure, and in older mice, OT 
treatment prevented the development of cardiac hypertrophy 
and dysfunction [88]. Moreover, OT was found to aid the 
myocardium recovery after ischemic injury in rats [89]. 
More recently, several studies have emerged 
demonstrating the physiological role of OT on skeletal 
muscles. Skeletal muscles have been shown to express OTR 
[90]. De Jager et al.’s work in cattle skeletal muscles indicated 
that OT may contribute to muscle growth as treatment with 
anabolic steroids led to increase in the expression of OT [91]. 
The role of OT in the increase in muscle mass was also 
examined in relation to aging. Muscle aging due to 
deficiency in muscle regeneration after injury or muscle 
atrophy has been identified to be mainly due to inhibition of 
the muscle stem cells. Circulating OT levels decrease after 
ovariectomy, which mimics hormonal aging, led to a 
hypothesis that OT may be a key age-specific determinant of 
skeletal muscle maintenance and repair. Elabd et al. 
demonstrated a dramatic decrease in OT and OTR in muscle 
stem cells with age, increase in muscle stem cell proliferation 
by OT supplement via MAPK/ERK pathway, and impaired 
muscle regeneration and premature development of 
sarcopenia in OT knockout mice [92]. Collectively, these 
findings indicate that OT plays a significant role in the 
age-specific regulation of myogenesis. OT could provide an 
easier and safer treatment for prevention of sarcopenia as 
modulating other signaling pathways such as TGF-β/pSmad 
and Wnt could result in severe side effects such as oncogenic 
transformations and immune deregulation [93, 94]. 
Conclusions 
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A large body of evidence emerged emphasizing the role of 
OT/OTR system in a wide range of physiological and 
behavioral processes. The effects of OT on myometrial 
tissues have been widely investigated, but less is known 
about the function of OT/OTR in other gestational tissues. 
The role of OT/OTR system appears to exceed the 
stimulation of uterine contractions and involves modulation 
of miRNAs and activation of inflammatory responses to 
mediate fetal membrane remodeling and cervical ripening. 
The effect of OTR gene polymorphisms contributing to the 
increased risk of PTB introduces a possibility of a candidate 
in the prediction as well as management of PTB. The 
findings reported on the novel role of OT in muscle 
maintenance and regeneration also opens up new therapeutic 
approaches for diseases affecting striated muscles. 
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